Fibroblast growth factor 21 is a novel hormonal regulator with the potential to treat a broad variety of metabolic abnormalities, such as type 2 diabetes, obesity, hepatic steatosis, and cardiovascular disease. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.